Response to Heard et al

EMBO J. 2015 Oct 1;34(19):2396-7. doi: 10.15252/embj.201592761.

Authors

Maryline Moulin¹, Anne K Voss², Tim Thomas², Wendy Wei-Lynn Wong³, Wendy D Cook⁴, Frank Koentgen⁵, James Vince², John Silke², David L Vaux²

Affiliations

¹ INSERM 1180, Université Paris Sud, Paris, France.
² The Walter and Eliza Hall Institute, Parkville, Vic., Australia Department of Medical Biology, The University of Melbourne, Parkville, Vic., Australia.
³ Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.
⁴ La Trobe Institute for Molecular Sciences, La Trobe University, Bundoora, Vic., Australia.
⁵ Ozgene Pty Ltd, Bentley DC, WA, Australia.

No abstract available

Publication types

Letter
Comment

MeSH terms

Animals
Female
Inhibitor of Apoptosis Proteins / metabolism*
Male
Receptor-Interacting Protein Serine-Threonine Kinases / metabolism*
Receptors, Tumor Necrosis Factor, Type I / metabolism*

Substances

Inhibitor of Apoptosis Proteins
Receptors, Tumor Necrosis Factor, Type I
Receptor-Interacting Protein Serine-Threonine Kinases